Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE